A $2.5 billion funding shortfall imperils malaria vaccine rollouts in sub-Saharan Africa

Funding cuts threaten the administration of malaria vaccines at the local level in endemic areas, increasing the risk of malaria cases and deaths in sub-Saharan Africa. The US and other donor countries have reduced funding for global malaria programs. Gavi, the Vaccine Alliance, is $2.5-$2.9 billion short of its $11.9 billion goal for 2026-2030. Thirteen percent of Gavi’s funding previously came from the US, with additional support from countries like the UK. Local health organizations in high-burden regions face constraints in delivering four-dose vaccine regimens. Reduced vaccine delivery increases the risk of malaria cases and deaths in sub-Saharan Africa.